SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000948046-13-000079
Filing Date
2013-07-12
Accepted
2013-07-12 16:58:59
Documents
6

Document Format Files

Seq Description Document Type Size
1 KV PHARMACEUTICAL SCHEDULE 13D kvpharmsc13d.htm SC 13D 134761
2 EX 99.1 - 2ND AR STOCK PURCHASE AND BACKSTOP AGREEMENT ex99-1.htm EX-1 1467353
3 EX 99.2 - PLAN SUPPORT AGREEMENT- ex99-2.htm EX-2 120155
4 EX 99.3 - SHARE PURCHASE AGREEMENT ex99-3.htm EX-3 82014
5 EX 99.4 - CHAPTER 11 PLAN ex99-4.htm EX-4 553529
6 EX 99.5 - FORM OF NEW STOCKHOLDERS AGREEMENT ex99-5.htm EX-5 147099
  Complete submission text file 0000948046-13-000079.txt   2506326
Mailing Address 2280 SCHUETZ ROAD ST. LOUIS MO 63146
Business Address 2280 SCHUETZ ROAD ST. LOUIS MO 63146 3146456600
KV PHARMACEUTICAL CO /DE/ (Subject) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D | Act: 34 | File No.: 005-12338 | Film No.: 13966483
SIC: 2834 Pharmaceutical Preparations

Mailing Address TAUNUSANLAGE 12 D-60325 FRANKFURT AM MAIN 2M 00000
Business Address TAUNUSANLAGE 12 D-60325 FRANKFURT AM MAIN GE 2M 00000 212 250 1540
DEUTSCHE BANK AG\ (Filed by) CIK: 0000948046 (see all company filings)

IRS No.: 132944988 | State of Incorp.: 2M
Type: SC 13D